Interleukin-6 genetic polymorphism and Chinese major depression

Neuropsychobiology

Volumn 52, Issue 4, 2005, Pages 202-205

  Hong, Chen Jee ^a,b   Yu, Younger W Y ^c   Chen, Tai Jui ^c,d   Tsai, Shih Jen ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c E DA HOSPITAL   (Taiwan)

^d I SHOU UNIVERSITY   (Taiwan)

Author keywords

Interleukin 6; Major depressive disorders; Polymorphism

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; DEPRESSIVE DISORDER, MAJOR; FEMALE; GENOTYPE; HUMANS; INTERLEUKIN-6; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS);

EID: 27944473582     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000089003     Document Type: Article

References (24)

1. Muller N, Ackenheil M: Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 1998;22:1-33.
2. Dunn AJ, Wang J, Ando T: Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress. Adv Exp Med Biol 1999;461:117-127.
3. Dantzer R, Wollman E, Vitkovic L, Yirmiya R: Cytokines and depression: fortuitous or causative association? Mol Psychiatry 1999;4:328-332.
4. Licinio J, Wong ML: The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry 1999;4:317-327.
5. Schobitz B, de Kloet ER, Sutanto W, Holsboer F: Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci 1993;5:1426-1435.
6. Maes M, Meltzer HY, Bosmans E, Bergmans R, Vandoolaeghe E, Ranjan R, Desnyder R: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 1995;34:301-309.
7. Sluzewska A, Rybakowski JK, Laciak M, Mackiewicz A, Sobieska M, Wiktorowicz K: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann N Y Acad Sci 1995;762:474-476.
8. Frommberger UH, Bauer J, Haselbauer P, Fraulin A, Riemann D, Berger M: Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci 1997;247:228-233.
9. Maes M, Bosmans E, De Jongh R, Kenis G, Vandoolaeghe E, Neels H: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment-resistant depression. Cytokine 1997;9:853-858.
10. Song C, Lin A, Bonaccorso S, Heide C, Verkerk R, Kenis G, Bosmans E, Scharpe S, Whelan A, Cosyns P, de Jongh R, Maes M: The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression. J Affect Disord 1998;49:211-219.
11. Brambilla F, Maggioni M: Blood levels of cytokines in elderly patients with major depressive disorder. Acta Psychiatr Scand 1998;97:309-313.
12. Kagaya A, Kugaya A, Takebayashi M, Fukue-Saeki M, Saeki T, Yamawaki S, Uchitomi Y: Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan. Neuropsychobiology 2001;43:59-62.
13. Levine J, Barak Y, Chengappa KN, Rapoport A, Rebey M, Barak V: Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999;40:171-176.
14. Stubner S, Schon T, Padberg F, Teipel SJ, Schwarz MJ, Haslinger A, Buch K, Dukoff R, Lasser R, Muller N, Sunderland T, Rapoport SI, Moller HJ, Hampel H: Interleukin-6 and the soluble IL-6 receptor are decreased in cerebrospinal fluid of geriatric patients with major depression: no alteration of soluble gp130. Neurosci Lett 1999;259:145-148.
15. Penninx BW, Kritchevsky SB, Yaffe K, Newman AB, Simonsick EM, Rubin S, Ferrucci L, Harris T, Pahor M: Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study. Biol Psychiatry 2003;54:566-572.
16. Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T: Interleukin-6 polymorphism (-634C/G) in the promoter region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 2002;19:1000-1005.
17. Yu YW, Chen TJ, Hong CJ, Chen HM and Tsai SJ: Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response. Neuropsychopharmacology 2003;28:1182-1185.
18. Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P: The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-1376.
19. Meenagh A, Williams F, Ross OA, Patterson C, Gorodezky C, Hammond M, Leheny WA, Middleton D: Frequency of cytokine polymorphisms in populations from western Europe, Africa, Asia, the Middle East and South America. Hum Immunol 2002;63:1055-1061.
20. Yamada Y, Ando F, Niino N, Shimokata H: Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 2003;88:3372-3378.
21. Winokur G: All roads lead to depression: clinically homogeneous, etiologically heterogeneous. J Affect Disord 1997;45:97-108.
22. Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, Pearce BD, Landry J, Glover S, McDaniel JS, Nemeroff CB: Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry 2001;158:1252-1257.
23. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690-1694.
24. Maes M, Scharpe S, Meltzer HY, Bosmans E, Suy E, Calabrese J, Cosyns P: Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 1993;49:11-27.